EIM
XENT

Essex Investment Management’s Intersect ENT, Inc XENT Stock Holding History

Essex Investment Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-56,728
Closed -$2.12M – 447
2018
Q2 		$2.12M Buy
56,728
+7
+0% +$275 0.27% 111
2018
Q1 		$2.23M Buy
+56,721
New +$2.07M 0.29% 104
2015
Q4 		– Sell
-21,239
Closed -$497K – 345
2015
Q3 		$497K Buy
+21,239
New +$586K 0.08% 230

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Essex Investment Management's XENT Position: Q3 2018 in Review

Essex Investment Management sold out of Intersect ENT, Inc (XENT) in Q3 2018, closing a stake of 56,728 shares — an estimated $2.12M sold.

Essex Investment Management first reported a position in XENT in Q3 2015 and held it in 3 quarters. The position peaked at $2.23M in Q1 2018. 138 funds tracked by Wall St. Rank hold XENT as of Q3 2018.

  • Essex Investment Management reported no remaining Intersect ENT, Inc position as of Q3 2018 after selling out during the quarter.
  • Essex Investment Management sold 56,728 Intersect ENT, Inc shares in Q3 2018, an estimated $2.12M.
  • Essex Investment Management first reported a position in Intersect ENT, Inc in Q3 2015 and held it in 3 quarters.
  • Essex Investment Management's Intersect ENT, Inc position peaked at $2.23M in Q1 2018.
  • 138 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2018.

Based on Essex Investment Management's 13F filing for Q3 2018, filed 16 Oct 2018.